PECAM1 and neoplasm: As shown in Fig. 6e and indicated by CD31 and CD105 staining, which showed a 37.4% and 15.2% decrease compared with control samples, respectively, #2714 significantly arrested the cell cycle and markedly decreased angiogenesis in LL/2 tumor tissues treated with #2714 for 14 days.